Taken together, our findings suggest that the differential ERβ activation including low expression in primary lung tumor tissues but high expression in matched metastatic lymph node, was one of the possible factors inducing NSCLC lymph node metastasis. This evidence concerns the gene ESR2 and non-small cell lung carcinoma.